Jupitab 10 Tablet contains Rosuvastatin 10mg, a potent lipid-lowering agent belonging to the statin class of medications. It is primarily indicated for the treatment of hypercholesterolemia and mixed dyslipidemia to reduce elevated total cholesterol, low-density lipoprotein cholesterol (LDL-C), apolipoprotein B, and triglycerides, while increasing high-density lipoprotein cholesterol (HDL-C). Rosuvastatin acts by selectively inhibiting HMG-CoA reductase, the rate-limiting enzyme in cholesterol biosynthesis, thereby decreasing cholesterol production in the liver and enhancing the clearance of LDL cholesterol from the bloodstream. Jupitab 10 is also prescribed for the prevention of cardiovascular disease in patients with risk factors such as type 2 diabetes, hypertension, or established coronary artery disease. The recommended dosage should be individualized based on the patient’s lipid profile and therapeutic response, with regular monitoring of liver function tests and creatine kinase levels to detect potential adverse effects. Common side effects may include headache, myalgia, abdominal pain, and nausea, while rare but serious adverse reactions include rhabdomyolysis and hepatotoxicity. Jupitab 10 should be used cautiously in patients with hepatic impairment or a history of muscle disorders and is contraindicated during pregnancy and lactation.